Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research.
作者信息
Dolan Deanne Dunbar, Cho Mildred K, Lee Sandra Soo-Jin
机构信息
Stanford University School of Medicine.
Columbia University.
出版信息
Am J Bioeth. 2023 Jul;23(7):1-4. doi: 10.1080/15265161.2023.2215201.
Abstract
摘要
相似文献
1
Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research.为基因组与精准医学研究的公正平等未来而创新。
Am J Bioeth. 2023 Jul;23(7):1-4. doi: 10.1080/15265161.2023.2215201.
2
The National Academies' Roundtable on Genomics and Precision Health: Where we have been and where we are heading.美国国家科学院基因组学与精准健康圆桌会议：我们的过去与未来
Am J Hum Genet. 2021 Oct 7;108(10):1817-1822. doi: 10.1016/j.ajhg.2021.08.015.
3
Getting It Right: How Public Engagement Might (and Might Not) Help Us Determine What Is Equitable in Genomics and Precision Medicine.把握正确方向：公众参与如何（以及可能无法）帮助我们确定基因组学和精准医学中的公平性问题。
Am J Bioeth. 2023 Jul;23(7):5-8. doi: 10.1080/15265161.2023.2215154.
4
Utility and Diversity: Challenges for Genomic Medicine.效用与多样性：基因组医学面临的挑战。
Annu Rev Genomics Hum Genet. 2021 Aug 31;22:1-24. doi: 10.1146/annurev-genom-120220-082640. Epub 2021 Apr 1.
5
Precision Medicine in Breast Cancer.乳腺癌中的精准医学
Radiol Technol. 2017 Mar;88(4):401M-421M.
6
Genomics and Precision Medicine: Implications for Critical Care.基因组学与精准医学：对重症监护的影响
AACN Adv Crit Care. 2018 Spring;29(1):28-35. doi: 10.4037/aacnacc2018521.
7
Equity in Genomic Medicine.基因组医学中的公平性。
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:613-625. doi: 10.1146/annurev-genom-112921-022635. Epub 2022 Apr 1.
8
The Precision Medicine Nation.精准医学国家
Hastings Cent Rep. 2017 Jul;47(4):19-29. doi: 10.1002/hast.736.
9
[Genomics-based precision medicine in hematology/oncology].[血液学/肿瘤学中基于基因组学的精准医学]
Rinsho Ketsueki. 2021;62(8):1004-1011. doi: 10.11406/rinketsu.62.1004.
10
Why Does the Shift from "Personalized Medicine" to "Precision Health" and "Wellness Genomics" Matter?为何从“个性化医疗”向“精准健康”和“健康基因组学”的转变至关重要？
AMA J Ethics. 2018 Sep 1;20(9):E881-890. doi: 10.1001/amajethics.2018.881.
引用本文的文献
1
Study design and the sampling of deleterious rare variants in biobank-scale datasets.生物样本库规模数据集中有害罕见变异的研究设计与抽样
Proc Natl Acad Sci U S A. 2025 Jun 10;122(23):e2425196122. doi: 10.1073/pnas.2425196122. Epub 2025 Jun 3.
2
Study design and the sampling of deleterious rare variants in biobank-scale datasets.生物样本库规模数据集中有害罕见变异的研究设计与抽样
bioRxiv. 2025 Jan 29:2024.12.02.626424. doi: 10.1101/2024.12.02.626424.
3
Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: A propensity score matching analysis of the SEER database.手术依从性对卵巢癌患者生存预后的影响及相关影响因素：基于监测、流行病学和最终结果（SEER）数据库的倾向评分匹配分析
Heliyon. 2024 Jun 25;10(13):e33639. doi: 10.1016/j.heliyon.2024.e33639. eCollection 2024 Jul 15.
4
Spotlighting Structural Constraints on Decisions About Participation in Genomic and Precision Medicine.聚焦参与基因组学与精准医学决策的结构限制因素
AJOB Empir Bioeth. 2024 Apr-Jun;15(2):87-92. doi: 10.1080/23294515.2024.2355893. Epub 2024 May 22.
5
Genomic Answers for Kids: Toward more equitable access to genomic testing for rare diseases in rural populations.儿童基因组解答：致力于让农村人口更公平地获得罕见病基因组检测服务。
Am J Hum Genet. 2024 May 2;111(5):825-832. doi: 10.1016/j.ajhg.2024.03.016. Epub 2024 Apr 17.
6
ACCESS: an empirically-based framework developed by the International Nursing CASCADE Consortium to address genomic disparities through the nursing workforce.ACCESS：一个由国际护理级联联盟开发的基于实证的框架，旨在通过护理人员解决基因组差异问题。
Front Genet. 2024 Jan 8;14:1337366. doi: 10.3389/fgene.2023.1337366. eCollection 2023.
本文引用的文献
1
Critiquing the Critique of Advocacy.对倡导之批判的批判
Am J Bioeth. 2023 Jul;23(7):97-99. doi: 10.1080/15265161.2023.2208073.
2
Ethical, Legal, and Social Implications of Genomics Research: Implications for Building a More Racially Diverse Bioethics Workforce.基因组学研究的伦理、法律和社会影响：对构建更具种族多样性的生物伦理劳动力队伍的影响。
Am J Bioeth. 2023 Jul;23(7):106-108. doi: 10.1080/15265161.2023.2207519.
3
Narrative Equity in Genomic Screening at the Population Level.
Am J Bioeth. 2023 Jul;23(7):121-123. doi: 10.1080/15265161.2023.2207548.
4
The Other Side of the Self-Advocacy Coin: How For-Profit Companies Can Divert the Path to Justice in Rare Disease.自我维权的另一面：营利性公司如何在罕见病领域偏离正义之路。
Am J Bioeth. 2023 Jul;23(7):88-91. doi: 10.1080/15265161.2023.2207521.
5
Bounded Justice, Inclusion, and the Hyper/Invisibility of Race in Precision Medicine.精准医学中的有界正义、包容以及种族的超隐形/隐形
Am J Bioeth. 2023 Jul;23(7):27-33. doi: 10.1080/15265161.2023.2207515. Epub 2023 May 23.
6
Promoting Equality in the Governance of Heritable Human Genome Editing through Ubuntu: Reflecting on a South African Public Engagement Study.通过乌班图促进可遗传人类基因组编辑治理中的平等：对南非公众参与研究的反思。
Am J Bioeth. 2023 Jul;23(7):43-49. doi: 10.1080/15265161.2023.2207524. Epub 2023 May 19.
7
Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care.罕见病、倡导和正义：研究和临床护理中的交叉差异。
Am J Bioeth. 2023 Jul;23(7):17-26. doi: 10.1080/15265161.2023.2207500. Epub 2023 May 19.
8
The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research.公众参与人类基因组编辑研究治理的前景与现实。
Am J Bioeth. 2023 Jul;23(7):9-16. doi: 10.1080/15265161.2023.2207502. Epub 2023 May 19.
9
Is It Just for a Screening Program to Give People All the Information They Want?是否只是为了筛查项目而向人们提供他们想要的所有信息？
Am J Bioeth. 2023 Jul;23(7):34-42. doi: 10.1080/15265161.2023.2207510. Epub 2023 May 12.
10
Community Engagement in Precision Medicine Research: Organizational Practices and Their Impacts for Equity.社区参与精准医学研究：组织实践及其对公平的影响。
AJOB Empir Bioeth. 2023;14(4):185-196. doi: 10.1080/23294515.2023.2201478. Epub 2023 May 1.
Zotero 插件